Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

China National Biotec Group Company Limited

Clinical trials sponsored by China National Biotec Group Company Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Do childhood vaccines last? 5-year follow-up study launched in china Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New infant vaccine aims to shield against three serious diseases

Vaccine Ongoing

This phase 3 study tests a new vaccine (DTacP) that protects infants from diphtheria, tetanus, and whooping cough. Around 2,900 healthy babies aged 2-3 months will receive the vaccine to check its safety and how well it triggers immunity. The trial compares different schedules an…

Phase 3 • Sponsor: China National Biotec Group Company Limited • Aim: Vaccine

Last updated Jun 26, 2026 17:26 UTC